Swedish Construction Stock News

If you are wondering whether EQT shares still offer value after a strong run, you are not alone. The stock recently closed at SEK 361.9, with returns of 1.4% over 7 days, 9.0% over 30 days, 1.0% year to date, 19.8% over 1 year, 44.1% over 3 years, and 85.9% over 5 years. This naturally raises questions about what is already priced in. Recent news flow around EQT has kept investor attention on how the business is positioned and how the market is reacting to its development. This context is...

By buying an index fund, investors can approximate the average market return. But if you buy good businesses at...

Key Insights The projected fair value for Elekta is kr115 based on 2 Stage Free Cash Flow to Equity Elekta is estimated...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") below 22x, you may consider...

As the European market shows signs of optimism with major stock indexes rising, investors are keenly observing opportunities that may be trading at a discount. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential growth prospects amidst a strengthening eurozone economy and favorable interest rates.

Xvivo Perfusion's (STO:XVIVO) stock is up by a considerable 21% over the past three months. As most would know...

Looking at NP3 Fastigheter AB (publ)'s ( STO:NP3 ) insider transactions over the last year, we can see that insiders...

Key Insights The projected fair value for Billerud is kr133 based on 2 Stage Free Cash Flow to Equity Billerud's...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Instalco's (STO:INSTAL) stock is up by a considerable 8.0% over the past month. However, we decided to pay attention to...

Key Insights Institutions' substantial holdings in Maha Capital implies that they have significant influence over the...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Despite an already strong run, Ovzon AB (publ) ( STO:OVZON ) shares have been powering on, with a gain of 25% in the...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Saab (OM:SAAB B) is back in focus after new European defence contracts for GlobalEye aircraft and RBS 70 Bolide missiles, along with progressing fighter program talks with Airbus that have reshaped attention on its long-term order visibility. See our latest analysis for Saab. The recent GlobalEye and missile contracts have arrived alongside sharp share price momentum, with a 34.33% 1 month share price return and a very large 5 year total shareholder return that points to strong, long running...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Significantly high institutional ownership implies AB Sagax's stock price is sensitive to their trading...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Betsson AB has published a prospectus and applied to list its €75 million senior unsecured, four-year floating-rate bonds on Nasdaq Stockholm, following approval from the Swedish Financial Supervisory Authority. The bond listing, issued under a €250 million framework, is intended to broaden Betsson’s access to capital markets to support its longer-term growth plans. We’ll now examine how Betsson’s move to list €75 million in senior unsecured bonds could influence its broader investment...

We feel now is a pretty good time to analyse Guard Therapeutics International AB (publ)'s ( STO:GUARD ) business as it...

With the business potentially at an important milestone, we thought we'd take a closer look at Xbrane Biopharma AB...